Suppr超能文献

成人至成人活体供肝移植相关的生存改善。

Improvement in survival associated with adult-to-adult living donor liver transplantation.

作者信息

Berg Carl L, Gillespie Brenda W, Merion Robert M, Brown Robert S, Abecassis Michael M, Trotter James F, Fisher Robert A, Freise Chris E, Ghobrial R Mark, Shaked Abraham, Fair Jeffrey H, Everhart James E

机构信息

Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.

出版信息

Gastroenterology. 2007 Dec;133(6):1806-13. doi: 10.1053/j.gastro.2007.09.004. Epub 2007 Sep 14.

Abstract

BACKGROUND & AIMS: More than 2000 adult-to-adult living donor liver transplantations (LDLT) have been performed in the United States, yet the potential benefit to liver transplant candidates of undergoing LDLT compared with waiting for deceased donor liver transplantation (DDLT) is unknown. The aim of this study was to determine whether there is a survival benefit of adult LDLT.

METHODS

Adults with chronic liver disease who had a potential living donor evaluated from January 1998 to February 2003 at 9 university-based hospitals were analyzed. Starting at the time of a potential donor's evaluation, we compared mortality after LDLT to mortality among those who remained on the waiting list or received DDLT. Median follow-up was 4.4 years. Comparisons were made by hazard ratios (HR) adjusted for LDLT candidate characteristics at the time of donor evaluation.

RESULTS

Among 807 potential living donor recipients, 389 underwent LDLT, 249 underwent DDLT, 99 died without transplantation, and 70 were awaiting transplantation at last follow-up. Receipt of LDLT was associated with an adjusted mortality HR of 0.56 (95% confidence interval [CI]: 0.42-0.74; P < .001) relative to candidates who did not undergo LDLT. As centers gained greater experience (>20 LDLT), LDLT benefit was magnified, with a mortality HR of 0.35 (95% CI: 0.23-0.53; P < .001).

CONCLUSIONS

Adult LDLT was associated with lower mortality than the alternative of waiting for DDLT. This reduction in mortality was magnified as centers gained experience with LDLT. This reduction in transplant candidate mortality must be balanced against the risks undertaken by the living donors themselves.

摘要

背景与目的

美国已开展了2000多例成人对成人活体肝移植(LDLT),但与等待尸体供肝肝移植(DDLT)相比,LDLT对肝移植受者的潜在益处尚不清楚。本研究的目的是确定成人LDLT是否具有生存获益。

方法

分析了1998年1月至2003年2月在9家大学附属医院接受潜在活体供者评估的慢性肝病成人患者。从潜在供者评估时开始,我们比较了LDLT后的死亡率与仍在等待名单上或接受DDLT者的死亡率。中位随访时间为4.4年。通过根据供者评估时LDLT受者特征调整的风险比(HR)进行比较。

结果

在807名潜在活体供者受者中,389例接受了LDLT,249例接受了DDLT,99例未移植死亡,70例在最后随访时仍在等待移植。与未接受LDLT的受者相比,接受LDLT者的校正死亡率HR为0.56(95%置信区间[CI]:0.42 - 0.74;P <.001)。随着中心经验的增加(>20例LDLT),LDLT的获益更加明显,死亡率HR为0.35(95%CI:0.23 - 0.53;P <.001)。

结论

成人LDLT与低于等待DDLT的死亡率相关。随着中心对LDLT经验的增加,这种死亡率的降低更加明显。这种移植受者死亡率的降低必须与活体供者自身承担的风险相权衡。

相似文献

1
Improvement in survival associated with adult-to-adult living donor liver transplantation.
Gastroenterology. 2007 Dec;133(6):1806-13. doi: 10.1053/j.gastro.2007.09.004. Epub 2007 Sep 14.
3
Defining long-term outcomes with living donor liver transplantation in North America.
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
6
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Am J Transplant. 2007 Jun;7(6):1601-8. doi: 10.1111/j.1600-6143.2007.01802.x.
10
Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
Pediatr Transplant. 2019 Dec;23(8):e13578. doi: 10.1111/petr.13578. Epub 2019 Sep 19.

引用本文的文献

1
Modern approach to hepatocellular carcinoma treatment.
World J Hepatol. 2025 Aug 27;17(8):107873. doi: 10.4254/wjh.v17.i8.107873.
4
American perspectives for LDLT in 2024.
Updates Surg. 2024 Sep 20. doi: 10.1007/s13304-024-01994-1.
5
Indications and results of right-lobe living donor liver transplantation.
Updates Surg. 2024 May 27. doi: 10.1007/s13304-024-01785-8.
6
Liver transplantation in Latin America: reality and challenges.
Lancet Reg Health Am. 2023 Nov 18;28:100633. doi: 10.1016/j.lana.2023.100633. eCollection 2023 Dec.
8
Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients.
Aging (Albany NY). 2023 Sep 2;15(17):8594-8612. doi: 10.18632/aging.204982.
9
Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
Transplantation. 2024 Mar 1;108(3):713-723. doi: 10.1097/TP.0000000000004767. Epub 2023 Aug 28.
10
Current Status of Living Donor Liver Transplantation: Impact, Advantages, and Challenges.
Curr Gastroenterol Rep. 2023 Oct;25(10):225-231. doi: 10.1007/s11894-023-00882-9. Epub 2023 Aug 21.

本文引用的文献

1
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation.
Hepatology. 2007 Nov;46(5):1476-84. doi: 10.1002/hep.21845.
2
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation.
Transplantation. 2007 Jun 15;83(11):1506-8. doi: 10.1097/01.tp.0000263343.21714.3b.
4
Deaths on the liver transplant waiting list: an analysis of competing risks.
Hepatology. 2006 Feb;43(2):345-51. doi: 10.1002/hep.21025.
5
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.
Ann Surg. 2005 Sep;242(3):314-23, discussion 323-5. doi: 10.1097/01.sla.0000179646.37145.ef.
6
The survival benefit of liver transplantation.
Am J Transplant. 2005 Feb;5(2):307-13. doi: 10.1111/j.1600-6143.2004.00703.x.
8
Allograft survival following adult-to-adult living donor liver transplantation.
Am J Transplant. 2004 Aug;4(8):1302-7. doi: 10.1111/j.1600-6143.2004.00522.x.
9
Improving liver allocation: MELD and PELD.
Am J Transplant. 2004;4 Suppl 9:114-31. doi: 10.1111/j.1600-6135.2004.00403.x.
10
Transplant data: sources, collection, and caveats.
Am J Transplant. 2004;4 Suppl 9:13-26. doi: 10.1111/j.1600-6135.2004.00395.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验